Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;12(8):9194-9201.
doi: 10.1002/cam4.5658. Epub 2023 Jan 27.

Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya

Nur Swaleh Said  1 , Amsalu Degu  1
Affiliations

Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya

Nur Swaleh Said et al. Cancer Med. 2023 Apr.

Abstract

Introduction: Lung cancer has a low overall survival rate linked to late diagnosis and metastasis. Unfortunately, comprehensive data within the African continent are limited due to the lack of a registry, low public awareness of lung cancer, financial constraints, and inadequate screening and treatment facilities. In addition, there was a lack of conclusive data in our setting. Therefore, this study aimed to assess survival outcomes among lung cancer patients at Kenyatta National Hospital.

Methods: A hospital-based retrospective cohort study was performed to examine the survival outcomes of 151 lung cancer patients. All eligible lung cancer patients diagnosed and treated in the facility between January 1, 2018, and December 31, 2020, were included. The patients were retrospectively followed from the date of primary cancer diagnosis until death or the last follow-up period. The Statistical Package for the Social Sciences (SPSS) version 20.0 statistical software was used to enter and analyze the data. Kaplan-Meier survival and Cox regression analysis were employed to determine median survival and predictors of mortality, respectively.

Results: The mean and median follow-time was 18.2 and 17.5 months, respectively. Most (98%) of the patients had non-small cell lung cancer. The 2-year survival rate was 66.7%, with 59.6% of patients having developed distant metastasis during the follow-up, while 25.1% were deceased. The median cancer-specific survival time among the study population was 18.0 ± 3.40 months. Cox regression analyses showed that patients with distant metastasis had five times more risk of dying (AHR: 4.74, 95% CI: 2.1-10.8, p < 0.001) than patients without distant metastasis.

Conclusions: The overall two-year survival rate of lung cancer patients at the Kenyatta National Hospital was 66.7%, with most patients developed distant metastasis during the follow-up period. Distant metastasis was the only significant predictor of mortality among lung cancer patients in our setting.

Keywords: Kenya; Kenyatta National Hospital; lung cancer; survival outcomes.

PubMed Disclaimer

Conflict of interest statement

The authors state that they do not have any conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209‐249. - PubMed
    1. Chen X, Mo S, Yi B. The spatiotemporal dynamics of lung cancer: 30‐year trends of epidemiology across 204 countries and territories. BMC Public Health. 2022;22(1):1‐13. - PMC - PubMed
    1. Dyba T, Randi G, Bray F, et al. The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308‐347. - PMC - PubMed
    1. Okonta KE, Echieh PC, Abubakar U, et al. Management of lung cancer in Africa: underdiagnosis and poor access to treatment ‐ a close look at Nigeria and West African sub‐region. J Pan African Thorac Soc. 2021;2(3):122‐129.
    1. Bogos K, Kiss Z, Tamási L, et al. Improvement in lung cancer survival: 6‐year trends of overall survival at Hungarian patients diagnosed in 2011‐2016. Pathol Oncol Res. 2021;27:603937. - PMC - PubMed